(Q53338395)

13 May 2018

title

Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism. (English)

1 reference

13 May 2018

author

José L. Mauriz

1

1 reference

13 May 2018

Javier González-Gallego

6

1 reference

13 May 2018

author name string

Paquita Gonzalez

2

1 reference

13 May 2018

M Cristina Duran

3

1 reference

13 May 2018

Virginia Molpeceres

4

1 reference

13 May 2018

Jesús M Culebras

5

1 reference

13 May 2018

publication date

1 January 2007

1 reference

13 May 2018

published in

Translational Research

1 reference

13 May 2018

volume

149

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

46-53

1 reference

13 May 2018

Estimating the world cancer burden: Globocan 2000.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Angiogenesis in ischemic and neoplastic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Participation of cyclin D1 deregulation in TNP-470-mediated cytostatic effect: involvement of senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor kappa B activation in a rat model of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

N-terminal processing: the methionine aminopeptidase and N alpha-acetyl transferase families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Cyclins, Cdks, and cyclin kinase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

CDK inhibitors: positive and negative regulators of G1-phase progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

To cycle or not to cycle: a critical decision in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Apoptosis and the cell cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

p53-dependent pathways of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Molecular pathogenesis of human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

New principle for the analysis of chemical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Bile acid secretion during rat liver carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Induction of S phase by G1 regulatory factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Expression of vascular endothelial growth factor in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

c-Met: structure, functions and potential for therapeutic inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

TNP-470 (AGM-1470): mechanisms of action and early clinical development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

The complexity of p53 modulation: emerging patterns from divergent signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.07.004

10.1016/J.TRSL.2006.07.004

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018